NOAH Trial Shows Survival Benefit With Neoadjuvant Trastuzumab

NOAH Trial Shows Survival Benefit With Neoadjuvant Trastuzumab In a phase III, international, open-label trial (Neoadjuvant Herceptin, NOAH), women with HER2-positive locally advanced or inflammatory breast cancer who received trastuzumab […]

Hem/Onc News

HEM/ONC News By Ellie Vershvovsky Rituximab Plus Bendamustine Outperforms Rituximab Plus CHOP in Indolent Lymphoma A phase III study, reported at the 51st annual American Society of […]

Hem/Onc News

By Ellie Vershvovsky The U.S. Food and Drug Administration (FDA) Approves New Treatment for Advanced Kidney Cancer On October 19, the FDA approved pazopanib (Votrient, GlaxoSmithKline) […]